Clinical Trials in Moore, Oklahoma
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled229 locationsNCT07181109
Recruiting
Phase 3
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence Study
Depression
Yale University400 enrolled6 locationsNCT06713616
Recruiting
The OBSERVE Protocol
Major Depression Disorder
Yale University450 enrolled6 locationsNCT06725277